Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
Clinical trial NCT00592553 · COMPLETED
Trial details
- NCT number
- NCT00592553
- Sponsor
- PTC Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-29
- Primary completion
- 2009-12-31
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.